BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pozzi S, Bari A, Pecherstorfer M, Vallet S. Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma. Cancers (Basel) 2021;13:4978. [PMID: 34638462 DOI: 10.3390/cancers13194978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Capalbo A, Lauritano C. Multiple Myeloma: Possible Cure from the Sea. Cancers (Basel) 2022;14:2965. [PMID: 35740630 DOI: 10.3390/cancers14122965] [Reference Citation Analysis]
2 Moschen AR, Sammy Y, Marjenberg Z, Heptinstall AB, Pooley N, Marczewska AM. The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients. Curr Oncol Rep 2022. [PMID: 35325401 DOI: 10.1007/s11912-022-01267-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ionova T, Vinogradova O, Kochkareva Y, Markova E, Kaplanov K, Shirokova M, Shelekhova T, Levanov A, Kopylova A, Li O, Mitina T, Rukavitsyn O, Simashova P, Anchukova L, Babich E, Volkova S, Dasheeva D, Demchenkova M, Dubov S, Esenina T, Ivanova L, Kravchuk T, Rimashevskaya E, Savinova M, Saraeva N, Porfirieva N, Nikitina TP, Ptushkin V. Quality of Life and Efficacy of Triplet IxaRd Therapy in Relapsed/Refractory Multiple Myeloma: Results of a Multi-Center Pilot Real-World Study. Клиническая онкогематология 2022;15:240-252. [DOI: 10.21320/2500-2139-2022-15-3-240-252] [Reference Citation Analysis]